MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome

S. Raju, K. Vyas (Bangalore, India)

Meeting: 2019 International Congress

Abstract Number: 1467

Keywords: Clonazepam, Tardive dyskinesia(TD)

Session Information

Date: Tuesday, September 24, 2019

Session Title: Drug-Induced Movement Disorders

Session Time: 1:45pm-3:15pm

Location: Agora 2 West, Level 2

Objective: To report a case of clonazepam induced withdrawal emergent dyskinesia.

Background: Withdrawal emergent syndrome was first described in 1973 when it was noticed that children abruptly withdrawn from chronic treatment with antipsychotic medication developed choreiform movements resembling Sydenham chorea. The condition, although often alarming, is self-limited and typically remits with discontinuation of the offending agent, usually within a few days. GABA is an important neurotransmitter in motor function, therefore an imbalance between GABA and dopamine could account for the incidences of TD in individuals who take anxiolytics. The benzodiazepine clonazepam is associated with TD when patients stop taking the medication acutely. Fast withdrawal from benzodiazepines can lead to withdrawal-emergent dyskinesia, a reversible form of TD, likely caused by the dopamine hypersensitivity.

Method: Case Report

Results: 62 year old Mister X presents with a history of involuntary movement of tongue since1 month, subacute onset with frequent episodes of repetitive, stereotypical, to and fro movements of tongue associated with drooling of saliva, difficulty in swallowing and speech with occasional tongue bite. Drug history- clonazepam 0.5 mg since 2 years. On examination- no kf ring, mmse 30/30, speech was dysarthric with tongue and oral dyskinesia. rest of the examination was normal. Investigation showed normal routine blood work up and serology. Peripheral smear for acanthocytes was normal. EEG, Echo was normal. MRI Brain was normal. Final Diagnosis -Withdrawal Emergent Syndrome due to Clonazepam.

Conclusion: Withdrawal Emergent Syndrome is a under reported entity in world literature. Anxiolytics including benzodiazepines are known to cause TD, Clonazepam which is a commonly used and abused drug can cause withdrawal emergent syndrome as illustrated in our case report, which is first of its kind in literature. Diazepam induced withdrawal symptoms has been reported in ten cases previously in 1982 but none on clonazepam. This insight will be helpfull to movement disorder and general clinicians to treat this uncommon drug induced movement disorder.

To cite this abstract in AMA style:

S. Raju, K. Vyas. Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/clonazepam-as-a-cure-or-a-cause-withdrawal-emergent-syndrome/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clonazepam-as-a-cure-or-a-cause-withdrawal-emergent-syndrome/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley